Valentyn Shapovalov

Valentyn Shapovalov

Auto-generated profile, based on publicly available information

Valentyn Shapovalov

Private Scientific Institution "Scientific and Research University of Medical and Pharmaceutical Law

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2023 in SSP Modern Pharmacy and Medicine
Verified
Journal Article
Open access
PDF file
VSValentyn Shapovalov
Valentyn Shapovalov
Multidisciplinary organizational and legal, forensic and pharmaceutical, clinical and pharmacological, forensic and medical, criminal and legal studies of medical errors in the system of legal relations between "doctor-patient-pharmacist-lawyer" were conducted. The implementation of the rules of the circulation of drugs established by the state in order to exclude forensic pharmaceutical risks and guarantee the safety of pharmacotherapy of patients was analyzed. Forensic and pharmaceutical analysis of patients' complaints indicates the need for further improvement of pharmaceutical provision and medical care. Normative measures have been developed for the prevention of medical errors during the circulation of drugs of clinical and pharmacological, classification and legal, nomenclature and legal groups.

24 February 2023 in SSP Modern Law and Practice
Verified
Journal Article
Open access
PDF file
OGOleksandr Gryzodub
Oleksandr Gryzodub
VSValentyn Shapovalov
Valentyn Shapovalov
The multidisciplinary context of the State Pharmacopoeia of Ukraine in drug quality systems was justified through an interdisciplinary study of pharmaceutical business organization, quality control, standardization, drug technology, management, marketing, forensic pharmacy, medical and pharmaceutical law in the system of legal relations "doctor-patient-pharmacist-lawyer" during state formation and implementation of Ukraine's integration processes into the WTO and the EU. Noted that the State Pharmacopoeia of Ukraine was from the first of the CIS countries, fully harmonized with the European Pharmacopoeia, takes into account national specificities, the Constitution of Ukraine, legislation on normative legal acts of Ukraine. Proven that, according to international assessments, the State Pharmacopoeia of Ukraine is the best National Pharmacopoeia in the post-Soviet space concerning the modern requirements of the WTO and WHO regarding quality and safety systems of medicines.

22 July 2022 in SSP Modern Law and Practice
Verified
Journal Article
Open access
PDF file
VSValentyn Shapovalov
Valentyn Shapovalov
OVOleksandr Veits
Oleksandr Veits
Based on the forensic and pharmaceutical, criminal and legal, social and economic research, analyzed the reasons and conditions causing bribery in the field of healthcare, committed by doctors who were officials. The analysis of the forensic and pharmaceutical practice on reports of the medical expertise commission showed that there is no information about the participation of lawyers in the system of legal relations "doctor-patient-investigator-lawyer". The obtained conclusions indicate that it is necessary to increase the level of advocacy during the investigation of criminal cases at the pre-trial and judicial investigation. In addition, in order to strengthen information co-operation between doctors and officials of healthcare institutions concerning the improvement of qualifications in matters of medical and pharmaceutical law of Ukraine, necessary measures were proposed. Normative initiatives to increase the level of criminal responsibility were given. Recommended to the leadership of the KhMAPE and Public Organization "Association of Medical and Pharmaceutical Law" to appeal with a corresponding initiative to the Ministry of Health of Ukraine, the Ministry of Internal Affairs of Ukraine, the Ministry of Internal Affairs of Ukraine, the Cabinet of Ministers of Ukraine to prevent the causes and conditions that cause bribery among communal non-profit enterprises – healthcare institutions.

14 October 2021 in SSP Modern Pharmacy and Medicine
Verified
Journal Article
Open access
PDF file
VSValentyn Shapovalov
Valentyn Shapovalov
LBLiubov Butko
Liubov Butko
The study is dedicated to legislative, normative, legal, and regulatory changes in the medical and educational sphere of activity, which occurred as a result of quarantine and introduction of restrictive anti-epidemic measures in order to prevent the spread of acute respiratory disease COVID-19 in Ukraine. It was noted that the changes in the legislation of Ukraine have significantly affected the medical and educational sphere of activity (doctors, pharmacists, teachers, students, listeners). The main prohibitions and permits in the work of specialists in medicine and education were given. The necessity of further studying the experience in the leading countries of the world on vaccination of different segments of the population is substantiated.

20 June 2025 in Proceeding of the Shevchenko Scientific Society. Medical Sciences
Verified
Journal Article
Open access
PDF file
ONOleksandr Nevzghoda
Oleksandr Nevzghoda
АОАліна Осинцева
Аліна Осинцева
VSViktoriia Shapovalova
Viktoriia Shapovalova
ITIurii Titarenko
Iurii Titarenko
VSValentyn Shapovalov
Valentyn Shapovalov
VDViktoria Dovzhuk
Viktoria Dovzhuk
Background. Chronic pancreatitis (CP) is a progressive inflammatory disease that leads to irreversible damage to the pancreas, causing exocrine and endocrine insufficiency. The optimization of CP pharmacotherapy is a critical issue due to the increasing prevalence of the disease and the need for cost-effective and evidence-based treatment strategies. The use of ABC/VED analysis provides an opportunity to classify and prioritize medications based on their clinical significance and economic feasibility. Objective. The study aimed to optimize the pharmacotherapy of chronic pancreatitis by applying ABC/VED analysis in the context of marketing and pharmacoeconomic research. Methods. The research included a comprehensive review of regulatory documents, clinical guidelines, and pharmacoeconomic evaluations. A multidisciplinary expert survey was conducted involving 50 healthcare professionals, including gastroenterologists, surgeons, endocrinologists, general practitioners, and pharmacists. ABC analysis was applied to classify medications based on their cost contribution, while VED analysis categorized drugs into vital (V), essential (E), and desirable (D) groups. The study also assessed the regulatory framework for CP pharmacotherapy at national and international levels. Results. The study identified inconsistencies between national and international regulatory documents regarding CP pharmacotherapy. Among 30 analyzed medications, five drugs (Imipenem + Cilastatin, Meropenem, Metronidazole, Cefotaxime, Ciprofloxacin) were included in all four regulatory documents. ABC analysis showed that 82.21% of total expenditures were allocated to category A drugs, 15.54% to category B, and 2.25% to category C. VED analysis revealed that 43% of drugs were classified as vital, while 57% were essential, with no drugs considered non-essential. A combined ABC/VED matrix indicated that category A/V drugs had the highest expenditure share (41.54%), highlighting their priority in CP treatment. Conclusions. The application of ABC/VED analysis in CP pharmacotherapy enables a structured and economically justified approach to medication selection. The study revealed regulatory discrepancies that may impact drug accessibility and treatment effectiveness. The findings provide evidence-based recommendations for optimizing CP pharmacotherapy, ensuring alignment with both international standards and national healthcare policies. Future research should focus on integrating pharmacoeconomic assessments into clinical decision-making and updating national treatment protocols accordingly.

24 February 2023 in SSP Modern Law and Practice
Verified
Journal Article
Open access
PDF file
VSValentyn Shapovalov
Valentyn Shapovalov
ASAndrey Samorodov
Andrey Samorodov
This article is devoted to the analysis of illegal drug circulation during the COVID-19 pandemic. The authors discuss the relationship between forensic pharmacy, pharmaceutical business management, and criminal law as a foundation for the interdisciplinary study of drug smuggling. The article examines various aspects of drug smuggling, including the production, transportation, and sale of drugs, as well as their impact on public health during the pandemic. The author also examines the problem of the development of international criminal networks involved in drug smuggling and points to the need for cooperation between countries to combat this phenomenon. Finally, the article discusses the impact of the pandemic on the growth of illegal drug circulation and the need for additional measures to combat this problem. The article also examines the role of the forensic pharmaceutical case in the fight against drug smuggling. The mechanisms of control over the production and supply of drugs are considered. The authors draw attention to the importance of preventing drug smuggling and provide recommendations to prevent the spread of this problem. In general, the article provides a holistic overview of the problem of drug smuggling during the COVID-19 pandemic, which is one of the most pressing problems today. The authors show that this phenomenon is a complex problem that requires cooperation between different disciplines and international organizations. The importance of solving this problem is to protect public health and maintain law and order.